Karyopharm Therapeutics Inc.KPTINASDAQ
LOADING
|||
Switch Symbol:
Revenue Performance
Above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$145.24M
↑ 73% above average
Average (9y)
$83.95M
Historical baseline
Range
High:$209.82M
Low:$154000.00
CAGR
+102.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $145.24M | -0.5% |
| 2023 | $146.03M | -7.0% |
| 2022 | $157.07M | -25.1% |
| 2021 | $209.82M | +94.1% |
| 2020 | $108.08M | +164.3% |
| 2019 | $40.89M | +34.8% |
| 2018 | $30.34M | +1790.1% |
| 2017 | $1.60M | +942.2% |
| 2016 | $154000.00 | -38.4% |
| 2015 | $250000.00 | - |